Page
%P
-
Article
Open AccessMET fusions and splicing variants convergently define a subgroup of glioma sensitive to MET inhibitors
Our previous study has shown that PTPRZ1-MET (ZM) fusion is a viable target for MET inhibitors in gliomas. However, the diversity and prevalence of somatic MET alterations in diffuse gliomas are still elusive and...